CNBC Stock Blog
- 10 Dividend Picks For Your Portfolio: Chief Investors
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Retail Earnings and Sales to Improve in Q4: Analyst
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
- Art Cashin: Caution 'Growing' in Financials, Dividend Moves
- 3 Software Stock Picks from Lazard's Senior Analyst
- Investors Bet on a New Year's Rally For eBay
- Why You Should Play the Reflation Trade: Stock Picker
MOST SHARED
- The Executive Job Search
- Chinese Overcapacity is Worsening, EU Chamber Warns
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Judge Erases Couple's $525,000 Mortgage Payment
- Salvation Army's Kettles Now Credit Card-Ready
- Topless Business Is Taking Off
- Wal-Mart Price Pressure Hurts China Workers: Report
- Black Friday: Bargain or Bust?
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Revenge of the Gangsta Nerds
- Will TCU See The "Flutie Effect?"
- Retail Earnings and Sales to Improve in Q4: Analyst
- Consumers Catching the Holiday Spirit
- It's Beginning To Look A Lot More Riskless
- Crescenzi: Claims Level Suggests End to Job Losses
- Hedge Funds Take Early Lead in Warren Buffett's 'Big Bet'
- Dubai Debt Delay Rattles Stock, Bond Markets
- Fannie Mae to Tighten Lending Standards: Report
- China Overcapacity Worsening, EU Chamber Warns
- Investing in Good Karma – and Making a Profit
- Black Friday to Avoid Red Ink; Greenback Gets the Blues
- Wal-Mart Price Pressure Hurts China Workers: Report
- Bankruptcies Jump, Hitting Highest Level in Four Years
- Steepest Black Friday Discounts, Revealed
- Where Do Pardoned Turkeys Go?
RSS FEED
Text Size 
writer, OptionMonster
Cubist Pharmaceuticals is rebounding from a three-month low, and some bulls are looking for a sharp surge higher amid buyout rumors.
OptionMonster's tracking systems detected unusual buying of the November 17.50 calls, with institutional-sized purchases pricing at $0.45 to $0.75. Volume surged to 3,882, more than four times existing open interest.
CBST stock [CBST
Loading...
()
] rose 1.69 percent to $17.74 in early afternoon trading but is down about 10 percent in the last three months. On Oct. 16, the biotechnology company reduced the sales forecast for Cubicin, its only product on the market.
The shares are climbing today amid unconfirmed takeover rumors and after bouncing off an old support level around $16.70. They need to climb roughly 4 percent by expiration for the calls purchased today to turn a profit.
The company is scheduled to participate in the Lazard Capital Markets 6th Annual Healthcare Conference on Nov. 18, one day before the calls expire.
Overall options volume in CBST is five times greater than average today, with calls outnumbering puts by 37 to 1.
___________________________
CNBC/OptionMonster Trading School:
___________________________
___________________________
David Russell is a reporter and writer for OptionMonster.
___________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes